Key Points
- Iron deficiency is extremely common in cardiac patients — particularly those with heart failure, chronic kidney disease, or those taking blood-thinning medications long-term.
- You do not need to be anaemic to be iron deficient. Many patients have low iron stores with a normal haemoglobin — and still experience significant fatigue and reduced exercise capacity.
- Medications including aspirin, dual antiplatelet therapy, and anticoagulants (blood thinners) can cause low-grade, ongoing gastrointestinal blood loss that slowly depletes iron stores over months to years.
- In heart failure, correcting iron deficiency — even without anaemia — significantly improves symptoms, exercise capacity, and quality of life, and reduces hospital admissions.
- When oral iron supplements are poorly tolerated or inadequately absorbed, intravenous iron infusion is safe, effective, and increasingly available.
- Iron levels are straightforward to check with a blood test. If you are experiencing unexplained fatigue and are on cardiac medications, asking your doctor about iron studies is worthwhile.
Iron deficiency and the heart have a closer connection than most people realise. It sits in the background of the cardiovascular conversation — overshadowed by cholesterol, blood pressure, and rhythm — and yet it is one of the most prevalent and most correctable problems in cardiac patients.
In cardiology and haematology clinics, iron deficiency turns up regularly. In patients on long-term blood thinners, in those managing heart failure, in people with chronic kidney disease. Recognising it, testing for it, and treating it effectively can make a profound difference to how a patient feels and functions day to day.
Iron Deficiency and the Heart — Why Are Cardiac Patients at Risk?
Several factors make cardiac patients particularly vulnerable to iron depletion. Understanding them helps explain why this problem is so common in this specific group.
Blood-Thinning Medications and Slow Blood Loss
Many cardiac patients take medications that reduce the blood’s ability to clot — aspirin, dual antiplatelet therapy (aspirin combined with clopidogrel or ticagrelor), or anticoagulants such as warfarin or DOACs (direct oral anticoagulants). These medications are essential and life-saving in the right context.
But they carry a side effect that is easy to overlook: low-grade, ongoing blood loss from the gastrointestinal tract. The gut lining is naturally prone to minor bleeding — small erosions and microscopic leaks that the body usually handles without consequence.
When platelet function is reduced or clotting is impaired, these tiny bleeds become slightly larger and slightly more persistent. Over months and years, the cumulative blood loss is enough to steadily deplete iron stores — even without any obvious sign of bleeding.
I see this regularly — a patient on long-term blood thinners who has been increasingly fatigued for months. Their haemoglobin is normal, so anaemia has been excluded. But their ferritin is very low and their iron stores are essentially empty. Correcting it changes everything.
— A/Prof. Ali Bazargan, Haematologist
| Medication | How It Can Deplete Iron | Risk Level |
|---|---|---|
| Aspirin | Reduces the blood’s clotting ability and can irritate the stomach lining, leading to minor ongoing blood loss | Moderate — increases with dose and duration |
| Dual antiplatelet therapy | Two clot-preventing medicines combined — greater stomach and gut bleeding risk than aspirin alone | Higher — particularly in first 12 months |
| Warfarin | Reduces the blood’s ability to clot — any gut bleed is larger and slower to stop | Moderate to high — especially when the blood-thinning effect is stronger than intended |
| DOACs (apixaban, rivaroxaban, dabigatran) | Direct blood thinners — gut bleeding risk varies by medication and dose | Moderate — rivaroxaban carries slightly higher gut bleeding risk than apixaban |
Heart Failure
Iron deficiency is extraordinarily common in heart failure — affecting up to 50% of patients with the condition. The reasons are multiple: reduced appetite, gut wall swelling that impairs iron absorption, and chronic low-grade inflammation that prevents iron from being properly used.
In some patients, underlying kidney disease compounds the problem further.
What makes this particularly important is that iron deficiency worsens heart failure outcomes independently of whether anaemia is present. The heart muscle itself requires iron for energy production. Iron-deficient cardiac muscle functions less efficiently — contributing directly to the breathlessness, fatigue, and exercise intolerance that define heart failure symptoms.
of patients with heart failure have iron deficiency — one of the most common and most treatable problems in this group, with or without anaemia
European Heart Journal
Chronic Kidney Disease
The kidneys play a central role in iron metabolism. They produce a hormone called erythropoietin — a chemical signal that tells the bone marrow to produce red blood cells, a process that requires iron. In chronic kidney disease, this signalling is impaired and iron utilisation breaks down.
Patients with chronic kidney disease are therefore at high risk of iron deficiency through multiple mechanisms simultaneously — reduced production, impaired utilisation, and often dietary restrictions or gut absorption problems on top.
Iron deficiency in this setting is a major driver of fatigue and anaemia, and managing it is an important part of comprehensive kidney and cardiac care.
Iron Deficiency Without Anaemia — Why This Matters
One of the most important things to understand is that iron deficiency and anaemia are not the same thing. Anaemia — a low haemoglobin or red cell count — is the late consequence of prolonged iron depletion.
Long before haemoglobin falls, iron stores in the body become exhausted. A patient with depleted iron stores but a normal haemoglobin has no anaemia — but they may have profound fatigue, reduced exercise capacity, impaired concentration, and poor quality of life.
The body is compensating, but at a cost. In heart failure particularly, this state of iron deficiency without anaemia is clinically significant and responds well to treatment.
| Blood Test | What It Measures | What Low Levels Mean |
|---|---|---|
| Ferritin | Iron storage protein — reflects total body iron stores | Low ferritin is the earliest marker of iron depletion — even with normal haemoglobin |
| Transferrin saturation (TSAT) | Percentage of iron-carrying protein that is actually carrying iron | Below 20% suggests iron is not being delivered to tissues adequately |
| Haemoglobin (Red blood cell) | Iron is attached to red blood cells. Oxygen requires attachment to the iron on red cells in order to be carried in circulation | Falls late in iron deficiency — a normal result does not exclude iron depletion |
| Serum iron | Iron circulating in the blood at the time of the test | Variable day-to-day — less reliable than ferritin or TSAT alone |
The Evidence for Treating Iron Deficiency in Heart Failure
The clinical trial evidence for intravenous iron in heart failure is now substantial. A large clinical trial (AFFIRM-AHF) showed that intravenous iron — given to iron-deficient patients hospitalised with acute heart failure — significantly reduced the risk of repeat heart failure admissions in the following year.
Patients also reported meaningful improvements in quality of life and their ability to be physically active.
A further large clinical trial (IRONMAN) added weight, showing that regular intravenous iron therapy reduced combined cardiovascular events and hospitalisations over a longer follow-up period. These trials have established correcting iron deficiency as a standard part of heart failure management — not an optional extra.
The AFFIRM-AHF data was genuinely practice-changing. We now routinely check iron studies in every heart failure patient — and treat deficiency proactively, not just when anaemia develops.
— Prof. Peter Barlis, Interventional Cardiologist
How Is Iron Deficiency Treated?
Treatment depends on the severity of deficiency, the underlying cause, and how well the gut can absorb oral iron.
Oral Iron Supplements
For mild iron deficiency without significant gut absorption problems, oral iron supplements — ferrous sulfate, ferrous fumarate, or ferrous gluconate — are a straightforward starting point. They are inexpensive and widely available.
The challenge is tolerability. Oral iron frequently causes nausea, constipation, and abdominal discomfort — particularly in older patients or those on multiple medications. Taking iron with food reduces side effects but also reduces absorption.
Alternate-day dosing has been shown to improve both absorption and tolerability compared to daily dosing, and is now commonly recommended. In patients with heart failure or chronic kidney disease, gut absorption is often impaired enough that oral iron cannot replenish stores adequately — even when tolerated. In these patients, intravenous iron is the more effective route.
Intravenous Iron Infusion
Intravenous iron bypasses the gut entirely, delivering iron directly into the bloodstream where it is immediately available for use. Modern iron preparations specifically designed for infusion — including Ferinject and Monofer — can deliver a large dose in a single session lasting around 15 minutes, making the treatment practical and efficient.
A cannula is placed in a vein in the arm, the infusion runs over the agreed time, and the patient goes home the same day. A small proportion of patients experience mild flushing, fever, hives, muscle ache, joint ache, or a temporary drop in phosphate levels — your team will advise on monitoring if needed. Very rarely, extravasation of iron under the skin can lead to marked discolouration. Serious reactions are rare with modern preparations.
For cardiac patients with significant heart failure and impaired gut absorption, intravenous iron is increasingly the first-line treatment of choice.
What to Expect — Iron Infusion
Preparation
Fasting is not usually required. A cannula is typically placed in the arm on arrival. The infusion generally takes around 15 minutes depending on the preparation used — your team will confirm the details beforehand.
During
Patients are typically monitored throughout. Mild flushing or warmth is common and usually passes quickly. Most people are able to read, use their phone, or rest comfortably during the infusion.
Afterwards
Most patients go home the same day. Many notice an improvement in energy and exercise capacity in the weeks that follow as iron stores are replenished — though timing varies from person to person.
Follow-up
Iron levels are typically rechecked after the infusion — your doctor will advise on timing. In some conditions such as heart failure or chronic kidney disease, repeat infusions may be needed over time.
Should You Ask About Your Iron Levels?
If you are a cardiac patient experiencing unexplained or worsening fatigue — and particularly if you are on long-term aspirin, dual antiplatelet therapy, or anticoagulation — asking your doctor to check a full iron study panel is entirely reasonable.
The test is simple, inexpensive, and the result is directly actionable. Iron studies include ferritin and transferrin saturation (TSAT) — both are needed, as ferritin alone can be falsely elevated by inflammation and may miss cases where iron stores appear normal but iron is not actually reaching the body’s tissues properly.
As a general guide, a ferritin below 100 micrograms per litre, or a transferrin saturation below 20%, may suggest iron deficiency is present — though your doctor will interpret these results in the context of your full clinical picture. You do not need to wait until you are anaemic. By that point, iron stores have been empty for some time — and earlier identification tends to lead to better outcomes.
Heart Matters Resource
When in Doubt, Get Checked Out
If you have heart failure, chronic kidney disease, or are on long-term blood-thinning medications and are experiencing significant fatigue — ask your doctor to check your iron studies. It is a simple test and a treatable problem.
Conclusion
Iron deficiency is common, underdiagnosed, and highly treatable in cardiac patients. Whether it arises from slow blood loss on blood-thinning therapy, from the metabolic demands of heart failure, or from the complex iron handling problems of chronic kidney disease — the end result is the same: depleted stores, profound fatigue, and a quality of life that does not have to be accepted as inevitable.
The evidence that treating iron deficiency in heart failure improves outcomes is now robust. The tools to do it — including intravenous iron infusion — are safe, practical, and increasingly accessible. What is needed is recognition that the problem exists in the first place.
If fatigue is limiting your life and you have not had your iron levels checked recently, that conversation with your doctor is worth having. It may be the most straightforward answer to a problem that has been hiding in plain sight.
More Reading
Our Heart Glossary explains terms like ferritin, haemoglobin, and transferrin saturation in plain language. Read our articles on fatigue and the heart and heart failure blood tests for related reading.
